Skip to main content

2025 IDWeek Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Session Icons

Live Streamed

On Demand

160 Views

A2. PK/PD studies

Poster Session: PK/PD Studies

(P-1232) Dose selection of obeldesivir for clinical evaluation in treatment of adult participants with respiratory syncytial virus infection

Tuesday, October 21, 2025

12:15 PM - 1:30 PM US ET

Location: Poster Hall B4-B5

Presenting Author(s)

Elham Amini, PharmD, PhD (she/her/hers)

Clinical Pharmacologist
Gilead Sciences, Inc.
Foster City, CA, United States

Co-Author(s)

ES

Eric Salgado, PhD

Gilead Sciences, Inc.
Foster City, California, United States
VC

Vincent Chang, PhD

Gilead Sciences, Inc.
Foster City, California, United States
SD

Santosh Davies, MD

Gilead Sciences, Inc.
Foster City, California, United States
DB

Darius Babusis, BA

Gilead Sciences, Inc.
Foster City, California, United States
JB

John P. Bilello, PhD

Gilead Sciences, Inc.
Foster City, California, United States
OF

Olivia Fu, MD

Gilead Sciences, Inc.
Foster City, California, United States
RH

Robert H. Hyland, DPhil

Gilead Sciences, Inc.
Foster City, California, United States
LC

Luzelena Caro, PhD

Gilead Sciences, Inc.
Foster City, California, United States